Merit Medical Systems
Merit Medical Systems, a healthcare firm, manufactures medical devices used in interventional cardiology and radiology procedures.
Launch date
Employees
Market cap
$5.6b
Enterprise valuation
$5.8b (Public information from Sep 2024)
Share price
$100.23 MMSI
South Jordan Utah (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 964m | 1.1b | 1.2b | 1.3b | 1.3b | 1.4b | 1.5b |
% growth | (3 %) | 12 % | 7 % | 9 % | 7 % | 7 % | 5 % |
EBITDA | 44.0m | 172m | 188m | 231m | 302m | 338m | 383m |
% EBITDA margin | 5 % | 16 % | 16 % | 18 % | 23 % | 24 % | 25 % |
Profit | (9.8m) | 48.5m | 74.5m | 94.4m | 125m | 151m | 169m |
% profit margin | (1 %) | 5 % | 6 % | 8 % | 9 % | 11 % | 11 % |
EV / revenue | 3.2x | 3.3x | 3.5x | 3.5x | 4.2x | 3.9x | 3.7x |
EV / EBITDA | 70.1x | 20.4x | 21.4x | 19.0x | 18.6x | 16.6x | 14.7x |
R&D budget | 57.8m | 71.2m | 82.2m | 84.3m | - | - | - |
R&D % of revenue | 6 % | 7 % | 7 % | 7 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $217m | Post IPO Equity | |
N/A | N/A | - | |
* | N/A | $850m | Post IPO Debt |
* | N/A | $650m | Post IPO Convertible |
Total Funding | - |
Related Content
Recent News about Merit Medical Systems
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Merit Medical Systems
EditACQUISITION by Merit Medical Systems Jul 2016
ACQUISITION by Merit Medical Systems Jun 2019